Genetic Evidence for GLP-1 and GIP Receptors as Targets for Treatment and Prevention of MASLD/MASH
Hits:
Institution:公共卫生学院
Title of Paper:Genetic Evidence for GLP-1 and GIP Receptors as Targets for Treatment and Prevention of MASLD/MASH
Journal:liver international
First Author:燕冉
Document Code:1867128814806601729
Translation or Not:No
Date of Publication:2024-11
Release Time:2025-10-06
Prev One:Efficient Mendelian randomization analysis with self-adaptive determination of sample structure and multiple pleiotropic effects
Next One:Pinpointing novel risk loci for Lewy body dementia and the shared genetic etiology with Alzheimer's disease and Parkinson's disease: a large-scale multi-trait association analysis.